Defining IL-6 levels in healthy individuals: A meta-analysis.
IL-6
blood
healthy
human
levels
Journal
Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
revised:
29
10
2020
received:
11
10
2020
accepted:
01
11
2020
pubmed:
7
11
2020
medline:
23
4
2021
entrez:
6
11
2020
Statut:
ppublish
Résumé
Interleukin-6 (IL-6) is produced by and impacts different cell types in human. IL-6 is associated with different diseases and viral infections, including COVID-19. To our knowledge, no normal values were reported for IL-6 in the blood of healthy individuals. We have reviewed and performed a meta-analysis on a total of 140 studies, including 12,421 values for IL-6 in the blood of healthy adult donors. Among these studies, 83 did not report a mean value and the standard deviation. Therefore, for the statistical analysis, we used the values reported in 57 studies, which included 3166 values for IL-6. The reported values for IL-6 in the blood of healthy donors varied between 0 and 43.5 pg/ml. The pooled estimate of IL-6 was 5.186 pg/ml (95% confidence interval [CI]: 4.631, 5.740). As the age increased by 1 year, IL-6 values increased by 0.05 pg/ml (95% CI: 0.02, 0.09; p < .01). Though the heterogenicity, as determined by I This is the first meta-analysis reporting the levels of IL-6 in the blood of healthy donors based on a large number of studies and donors. Therefore the 95% CI values determined in our study could well serve as a reference range for quick decision-making in clinical interventions, particularly those aiming to inhibit IL-6, especially urgent interventions, for example, COVID-19.
Sections du résumé
BACKGROUND
Interleukin-6 (IL-6) is produced by and impacts different cell types in human. IL-6 is associated with different diseases and viral infections, including COVID-19. To our knowledge, no normal values were reported for IL-6 in the blood of healthy individuals. We have reviewed and performed a meta-analysis on a total of 140 studies, including 12,421 values for IL-6 in the blood of healthy adult donors. Among these studies, 83 did not report a mean value and the standard deviation. Therefore, for the statistical analysis, we used the values reported in 57 studies, which included 3166 values for IL-6.
RESULTS
The reported values for IL-6 in the blood of healthy donors varied between 0 and 43.5 pg/ml. The pooled estimate of IL-6 was 5.186 pg/ml (95% confidence interval [CI]: 4.631, 5.740). As the age increased by 1 year, IL-6 values increased by 0.05 pg/ml (95% CI: 0.02, 0.09; p < .01). Though the heterogenicity, as determined by I
CONCLUSIONS
This is the first meta-analysis reporting the levels of IL-6 in the blood of healthy donors based on a large number of studies and donors. Therefore the 95% CI values determined in our study could well serve as a reference range for quick decision-making in clinical interventions, particularly those aiming to inhibit IL-6, especially urgent interventions, for example, COVID-19.
Substances chimiques
IL6 protein, human
0
Interleukin-6
0
Types de publication
Journal Article
Meta-Analysis
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
3915-3924Informations de copyright
© 2020 Wiley Periodicals LLC.
Références
Naka T, Nishimoto N, Kishimoto T. The paradigm of IL-6: from basic science to medicine. Arthritis Res. 2002;4(Suppl 3):S233-S242.
Puel A, Casanova JL. The nature of human IL-6. J Exp Med. 2019;216(9):1969-1971.
Kaur S, Bansal Y, Kumar R, Bansal G. A panoramic review of IL-6: structure, pathophysiological roles and inhibitors. Bioorg Med Chem. 2020;28(5):115327.
Velazquez-Salinas L, Verdugo-Rodriguez A, Rodriguez LL, Borca MV. The role of interleukin 6 during viral infections. Front Microbiol. 2019;10:1057.
Chhetri S, Khamis F, Pandak N, Al-Khalili H, Said E, Petersend E. A fatal case of COVID-19 due to metabolic acidosis following dysregulate inflammatory response (cytokine storm). IDCases. 2020;21: e00829.
Ulhaq ZS, Soraya GV. Interleukin-6 as a potential biomarker of COVID-19 progression. Med Mal Infect. 2020;50(4):382-383.
Xu X, Han M, Li T, et al. Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci U S A. 2020;117(20):10970-10975.
Wyczalkowska-Tomasik A, Czarkowska-Paczek B, Zielenkiewicz M, Paczek L. Inflammatory markers change with age, but do not fall beyond reported normal ranges. Arch Immunol Ther Exp (Warsz). 2016;64(3):249-254.
Said EA, Al-Abri MA, Al-Saidi I, et al. Altered blood cytokines, CD4 T cells, NK and neutrophils in patients with obstructive sleep apnea. Immunol Lett. 2017;190:272-278.
Said EA, Dupuy FP, Trautmann L, et al. Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection. Nat Med. 2010;16(4):452-459.
Pan F, Xiang H, Yan J, et al. Dendritic cells from rheumatoid arthritis patient peripheral blood induce Th17 cell differentiation via miR-363/integrin alphav/TGF-beta axis. Scand J Immunol. 2017;85(6):441-449.
Peiravian F, Rajaian H, Samiei A, et al. Altered serum cytokine profiles in relapse phase of relapsing-remitting multiple sclerosis. Iran J Immunol. 2016;13(3):186-196.
Rendon-Ramirez EJ, Ortiz-Stern A, Martinez-Mejia C, et al. TGF-beta blood levels distinguish between influenza A (H1N1)pdm09 virus sepsis and sepsis due to other forms of community-acquired pneumonia. Viral Immunol. 2015;28(5):248-254.
Rios-Toro JJ, Marquez-Coello M, Garcia-Alvarez JM, et al. Soluble membrane receptors, interleukin 6, procalcitonin and C reactive protein as prognostic markers in patients with severe sepsis and septic shock. PLOS One. 2017;12(4):e0175254.
Sanchez-Zauco N, Torres J, Gomez A, et al. Correction to: Circulating blood levels of IL-6, IFN-gamma, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study. BMC Cancer. 2017;17(1):669.
Sánchez-Zauco N, Torres J, Gómez A, et al. Circulating blood levels of IL-6, IFN-γ, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study. BMC Cancer. 2017;17(1):384.
Song J, Park DW, Moon S, et al. Diagnostic and prognostic value of interleukin-6, pentraxin 3, and procalcitonin levels among sepsis and septic shock patients: a prospective controlled study according to the sepsis-3 definitions. BMC Infect Dis. 2019;19(1):968.
Ataseven A, Kesli R, Kurtipek GS, Ozturk P. Assessment of lipocalin 2, clusterin, soluble tumor necrosis factor receptor-1, interleukin-6, homocysteine, and uric acid levels in patients with psoriasis. Dis Markers. 2014;2014:541709-7.
Karaguzel EO, Arslan FC, Uysal EK, et al. Blood levels of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha and cognitive functions in patients with obsessive compulsive disorder. Compr Psychiatry. 2019;89:61-66.
Lu J, Ma SS, Zhang WY, Duan JP. Changes in peripheral blood inflammatory factors (TNF-α and IL-6) and intestinal flora in AIDS and HIV-positive individuals. J Zhejiang Univ Sci B. 2019;20(10):793-802.
Vicennati V, Vottero A, Friedman C, Papanicolaou DA. Hormonal regulation of interleukin-6 production in human adipocytes. Int J Obes Relat Metab Disord. 2002;26(7):905-911.
Pedersen BK, Febbraio MA. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev. 2008;88(4):1379-1406.
Maggio M, Guralnik JM, Longo DL, Ferrucci L. Interleukin-6 in aging and chronic disease: a magnificent pathway. J Gerontol A Biol Sci Med Sci. 2006;61(6):575-584.
Rossi JF, Lu ZY, Jourdan M, Klein B. Interleukin-6 as a therapeutic target. Clin Cancer Res. 2015;21(6):1248-1257.
Roche initiates phase III clinical trial of Actemra/RoActemra plus remdesivir in hospitalised patients with severe COVID-19 pneumonia. https://www.roche.com/media/releases/med-cor-2020-05-28.htm
Al-Mazidi S, Farhat K, Nedjadi T, et al. Association of interleukin-6 and other cytokines with self-reported pain in prostate cancer patients receiving chemotherapy. Pain Med. 2017;19(5):1058-1066.
Alper B, Erdogan B, Erdogan MÖ, Bozan K, Can M. Associations of trauma severity with mean platelet volume and levels of systemic inflammatory markers (IL1β, IL6, TNFα, and CRP). Mediators Inflamm. 2016;2016:9894716.
Ambreen F, Ismail M, Qureshi IZ. Association of gene polymorphism with serum levels of inflammatory and angiogenic factors in Pakistani patients with age-related macular degeneration. Mol Vision. 2015;21:985-999.
Aziz N, Detels R, Quint JJ, Gjertson D, Ryner T, Butch AW. Biological variation of immunological blood biomarkers in healthy individuals and quality goals for biomarker tests. BMC Immunol. 2019;20(1):33.
Azizi E, Zavaran Hosseini A, Soudi S, Noorbala AA. Alteration of Serum levels of cytokines in schizophrenic patients before and after treatment with risperidone. Iran J Allergy Asthma Immunol. 2019;18(3):262-268.
Bodienkova G, Alekseev R, Boklazhenko E, Kurchevenko S. Inflammation mediators in employees in chronic exposure to neurotoxicants. Int J Occup Med Environ Health. 2014;27(4):619-626.
Cantó E, Zamora C, Garcia-Planella E, et al. Bacteria-related events and the immunological response of onset and relapse adult Crohn's disease patients. J Crohn's Colitis. 2018;13(1):92-99.
Avci Çiçek E, Rota S, Dursun B, Kavalci E. Evaluation of serum NGAL and hepcidin levels in chronic kidney disease patients. Ren Fail. 2016;38(1):35-39.
Domingos JA, Soares LS, Bandeira LM, et al. Cytokine profile and proviral load among Japanese immigrants and non-Japanese infected with HTLV-1 in a non-endemic area of Brazil. PLOS One. 2017;12(4):e0174869.
Du S, Sun Y, Zhao B. Interleukin-6 serum levels are elevated in individuals with degenerative cervical myelopathy and are correlated with symptom severity. Med Sci Monit. 2018;24:7405-7413.
Ellulu MS, Rahmat A, Patimah I, Khaza'ai H, Abed Y. Effect of vitamin C on inflammation and metabolic markers in hypertensive and/or diabetic obese adults: a randomized controlled trial. Drug Des Devel Ther. 2015;9:3405-3412.
Fadaei R, Bagheri N, Heidarian E, et al. Serum levels of IL-32 in patients with type 2 diabetes mellitus and its relationship with TNF-alpha and IL-6. Cytokine. 2020;125:154832.
Gasiorowska A, Talar-Wojnarowska R, Kaczka A, Borkowska A, Czupryniak L, Małecka-Panas E. Subclinical inflammation and endothelial dysfunction in patients with chronic pancreatitis and newly diagnosed pancreatic cancer. Dig Dis Sci. 2016;61(4):1121-1129.
Gibas-Dorna M, Nowak D, Piatek J, Pupek-Musialik D, Krauss H, Kopczynski P. Plasma ghrelin and interleukin-6 levels correlate with body mass index and arterial blood pressure in males with essential hypertension. J Physiol Pharmacol. 2015;66(3):367-372.
Goetzl EJ, Schwartz JB, Abner EL, Jicha GA, Kapogiannis D. High complement levels in astrocyte-derived exosomes of Alzheimer disease. Ann Neurol. 2018;83(3):544-552.
Gutkowski K, Gutkowska D, Kiszka J, et al. Serum interleukin-17 levels predict inflammatory activity in patients with autoimmune hepatitis. Pol Arch Med Wewn. 2018;128(3):150-156.
Handley R, Mondelli V, Zelaya F, et al. Effects of antipsychotics on cortisol, interleukin-6 and hippocampal perfusion in healthy volunteers. Schizophr Res. 2016;174(1-3):99-105.
Heydari F, Rostami-Nejad M, Moheb-Alian A, et al. Serum cytokines profile in treated celiac disease compared with non-celiac gluten sensitivity and control: a marker for differentiation. J Gastrointestin Liver Dis. 2018;27(3):241-247.
Jiang C, Kong W, Wang Y, et al. Changes in the cellular immune system and circulating inflammatory markers of stroke patients. Oncotarget. 2016;8(2):3553-3567.
Kageyama Y, Kasahara T, Kato M, et al. The relationship between circulating mitochondrial DNA and inflammatory cytokines in patients with major depression. J Affect Disord. 2018;233:15-20.
Kalmady SV, Venkatasubramanian G, Shivakumar V, et al. Relationship between Interleukin-6 gene polymorphism and hippocampal volume in antipsychotic-naïve schizophrenia: evidence for differential susceptibility? PLOS One. 2014;9(5):e96021.
Koca YS, Bulbul M, Barut I. The diagnostic roles of cytokines in hepatobiliary cancers. BioMed Res Int. 2017;2017:2979307.
Lee JB, Shin YO. Oligonol supplementation affects leukocyte and immune cell counts after heat loading in humans. Nutrients. 2014;6(6):2466-2477.
Li X, Wang Y, Han C, Li P, Zhang H. Colorectal cancer progression is associated with accumulation of Th17 lymphocytes in tumor tissues and increased serum levels of interleukin-6. Tohoku J Exp Med. 2014;233(3):175-182.
Martinez-Fierro ML, Garza-Veloz I, Rocha-Pizaña MR, et al. Serum cytokine, chemokine, and growth factor profiles and their modulation in inflammatory bowel disease. Medicine (Baltimore). 2019;98(38):e17208.
Moradi N, Fadaei R, Khamseh ME, et al. Serum levels of CTRP3 in diabetic nephropathy and its relationship with insulin resistance and kidney function. PLOS One. 2019;14(4):e0215617.
Mortazavi H, Esmaili N, Khezri S, et al. The effect of conventional immunosuppressive therapy on cytokine serum levels in pemphigus vulgaris patients. Iran J Allergy Asthma Immunol. 2014;13(3):174-183.
Okamoto LE, Raj SR, Gamboa A, et al. Sympathetic activation is associated with increased IL-6, but not CRP in the absence of obesity: lessons from postural tachycardia syndrome and obesity. Am J Physiol: Heart Circ Physiol. 2015;309(12):H2098-H2107.
Patel SR, Singh A, Misra V, Misra SP, Dwivedi M, Trivedi P. Levels of interleukins 2, 6, 8, and 10 in patients with irritable bowel syndrome. Indian J Pathol Microbiol. 2017;60(3):385-389.
Patro ARK, Mohanty S, Prusty BK, et al. Cytokine signature associated with disease severity in dengue. Viruses. 2019;11:1.
Rashed L, Abdel Hay R, Mahmoud R, Hasan N, Zahra A, Fayez S. Association of angiotensin-converting enzyme (ACE) gene polymorphism with inflammation and cellular cytotoxicity in vitiligo patients. PLOS One. 2015;10(7):e0132915.
Rong Y-D, Bian A-L, Hu H-Y, Ma Y, Zhou X-Z. Study on relationship between elderly sarcopenia and inflammatory cytokine IL-6, anti-inflammatory cytokine IL-10. BMC Geriatr. 2018;18(1):308.
Shen L, Wang S, Ling Y, Liang W. Association of C1q/TNF-related protein-1 (CTRP1) serum levels with coronary artery disease. J Int Med Res. 2019;47(6):2571-2579.
Silva EM, Mariano VS, Pastrez PRA, et al. High systemic IL-6 is associated with worse prognosis in patients with non-small cell lung cancer. PLOS One. 2017;12(7):e0181125.
Solus JF, Chung CP, Oeser A, et al. Genetics of serum concentration of IL-6 and TNFalpha in systemic lupus erythematosus and rheumatoid arthritis: a candidate gene analysis. Clin Rheumatol. 2015;34(8):1375-1382.
Steptoe A, Hiltl T-J, Dowd JB, Hamer M. Socioeconomic status and central adiposity as determinants of stress-related biological responses relevant to cardiovascular disease risk. Brain Behav Immun. 2019;77:16-24.
Tsai C-F, Chu C-J, Huang Y-H, et al. Detecting minimal hepatic encephalopathy in an endemic country for hepatitis B: the role of psychometrics and serum IL-6. PLOS One. 2015;10(6):e0128437.
Uludag IF, Duksal T, Tiftikcioglu BI, Zorlu Y, Ozkaya F, Kirkali G. IL-1beta, IL-6 and IL1Ra levels in temporal lobe epilepsy. Seizure. 2015;26:22-25.
Umare V, Nadkarni A, Nadkar M, et al. Do high sensitivity C-reactive protein and serum interleukin-6 levels correlate with disease activity in systemic lupus erythematosuspatients? J Postgrad Med. 2017;63(2):92-95.
Walborn A, Hoppensteadt D, Syed D, Mosier M, Fareed J. Biomarker profile of sepsis-associated coagulopathy using biochip assay for inflammatory cytokines. Clin Appl Thromb Hemost. 2018;24(4):625-632.
Wang XH, Liu SQ, Wang YL, Jin Y. Correlation of serum high-sensitivity C-reactive protein and interleukin-6 in patients with acute coronary syndrome. Genet Mol Res. 2014;13(2):4260-4266.
Wang X, Li Y, Gao S, et al. Increased serum levels of lipocalin-1 and -2 in patients with stable chronic obstructive pulmonary disease. Int J Chronic Obstruct Pulm Dis. 2014;9:543-549.
Wang X-B, Wu D-J, Chen W-P, Liu J, Ju Y-J. Impact of radiotherapy on immunological parameters, levels of inflammatory factors, and clinical prognosis in patients with esophageal cancer. J Radiat Res. 2019;60(3):353-363.
Xia S, Sun Q, Zou Z, et al. Ginkgo biloba extract attenuates the disruption of pro-and anti-inflammatory T-cell balance in peripheral blood of arsenicosis patients. Int J Biol Sci. 2020;16(3):483-494.
Xu Y, Huang Q, Zhang W, et al. Decreased expression levels of Nurr1 are associated with chronic inflammation in patients with type 2 diabetes. Mol Med Rep. 2015;12(4):5487-5493.
Yang M, Zhou X, Xu J, et al. Association of serum chemerin and inflammatory factors with type 2 diabetes macroangiopathy and waist-to-stature ratio. Bosn J Basic Med Sci. 2019;19(4):328-335.
Yu H, Chen K, Sun Y, et al. Cytokines are markers of the Clostridium difficile-induced inflammatory response and predict disease severity. Clin Vaccine Immunol. 2017;24(8):e00037-17.